WO2010067617A1 - Structure de membrane lipidique - Google Patents

Structure de membrane lipidique Download PDF

Info

Publication number
WO2010067617A1
WO2010067617A1 PCT/JP2009/006783 JP2009006783W WO2010067617A1 WO 2010067617 A1 WO2010067617 A1 WO 2010067617A1 JP 2009006783 W JP2009006783 W JP 2009006783W WO 2010067617 A1 WO2010067617 A1 WO 2010067617A1
Authority
WO
WIPO (PCT)
Prior art keywords
lipid membrane
membrane structure
lipid
gene
gala
Prior art date
Application number
PCT/JP2009/006783
Other languages
English (en)
Japanese (ja)
Inventor
原島秀吉
秋田英万
増田智也
石原一彦
金野智浩
Original Assignee
国立大学法人 北海道大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 国立大学法人 北海道大学 filed Critical 国立大学法人 北海道大学
Publication of WO2010067617A1 publication Critical patent/WO2010067617A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

L'invention porte sur une structure de membrane lipidique destinée à administrer une substance telle qu'un composant pharmaceutiquement efficace ou un acide nucléique à un tissu ou organe cible (par exemple, le foie). La structure de membrane lipidique se trouve sous la forme d'un liposome modifié en surface par un polymère MPC et GALA, ou similaire.
PCT/JP2009/006783 2008-12-12 2009-12-11 Structure de membrane lipidique WO2010067617A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008-317377 2008-12-12
JP2008317377 2008-12-12

Publications (1)

Publication Number Publication Date
WO2010067617A1 true WO2010067617A1 (fr) 2010-06-17

Family

ID=42242609

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2009/006783 WO2010067617A1 (fr) 2008-12-12 2009-12-11 Structure de membrane lipidique

Country Status (1)

Country Link
WO (1) WO2010067617A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012124688A1 (fr) * 2011-03-14 2012-09-20 国立大学法人北海道大学 Vecteur pour administration pulmonaire, agent d'induction, et utilisations
CN103588933A (zh) * 2013-10-10 2014-02-19 西北大学 多重仿生抗生物污染共聚物及其制备方法和应用
WO2018150429A1 (fr) * 2017-02-16 2018-08-23 Yeda Research And Development Co. Ltd. Véhicules liposomaux pour l'administration de médicaments
WO2019111415A1 (fr) * 2017-12-08 2019-06-13 ワミレスコスメティックス株式会社 Vésicule cationisée, et composition associée

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06178930A (ja) * 1992-12-15 1994-06-28 Pola Chem Ind Inc 被膜安定化リポソーム及びその製造方法
JP2000001416A (ja) * 1998-06-12 2000-01-07 Pola Chem Ind Inc ポリオール含有リポソーム
WO2008105178A1 (fr) * 2007-02-28 2008-09-04 National University Corporation Hokkaido University Agent utilisé pour améliorer la résistance d'un liposome contre un constituant biologique et liposome modifié avec ledit agent

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06178930A (ja) * 1992-12-15 1994-06-28 Pola Chem Ind Inc 被膜安定化リポソーム及びその製造方法
JP2000001416A (ja) * 1998-06-12 2000-01-07 Pola Chem Ind Inc ポリオール含有リポソーム
WO2008105178A1 (fr) * 2007-02-28 2008-09-04 National University Corporation Hokkaido University Agent utilisé pour améliorer la résistance d'un liposome contre un constituant biologique et liposome modifié avec ledit agent

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HIDETAKA AKITA ET AL.: "Development of multifunctional envelope-type nano-device (MEND) based on the regulation of intracellular trafficking", DRUG DELIVERY SYSTEM, vol. 22-2, 7 June 2007 (2007-06-07), pages 115 - 122 *
HIDEYOSHI HARASHIMA ET AL., YAKUGAKU ZASSHI, vol. 127, no. 10, 2007, pages 1655 - 1672 *
KENTARO KOGURE ET AL., YAKUGAKU ZASSHI, vol. 128, no. 2, February 2008 (2008-02-01), pages 219 - 232 *

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012124688A1 (fr) * 2011-03-14 2012-09-20 国立大学法人北海道大学 Vecteur pour administration pulmonaire, agent d'induction, et utilisations
JP5850915B2 (ja) * 2011-03-14 2016-02-03 国立大学法人北海道大学 肺送達のためのベクター、導入剤及び使用
US9532950B2 (en) 2011-03-14 2017-01-03 National University Corporation Hokkaido University Vector for pulmonary delivery, inducing agent, and uses
CN103588933A (zh) * 2013-10-10 2014-02-19 西北大学 多重仿生抗生物污染共聚物及其制备方法和应用
CN103588933B (zh) * 2013-10-10 2016-09-07 西北大学 多重仿生抗生物污染共聚物及其制备方法和应用
CN110612097A (zh) * 2017-02-16 2019-12-24 耶达研究及发展有限公司 脂质体药物递送媒介物
IL268714A (en) * 2017-02-16 2019-10-31 Klein Jacob Liposome preparation for drug administration
WO2018150429A1 (fr) * 2017-02-16 2018-08-23 Yeda Research And Development Co. Ltd. Véhicules liposomaux pour l'administration de médicaments
US11684578B2 (en) 2017-02-16 2023-06-27 Yeda Research And Development Co. Ltd. Liposomic drug-delivery vehicles
IL291628B1 (en) * 2017-02-16 2023-09-01 Yeda res & development co ltd A liposomal preparation for drug administration
CN110612097B (zh) * 2017-02-16 2023-10-20 耶达研究及发展有限公司 脂质体药物递送媒介物
WO2019111415A1 (fr) * 2017-12-08 2019-06-13 ワミレスコスメティックス株式会社 Vésicule cationisée, et composition associée
JPWO2019111415A1 (ja) * 2017-12-08 2020-04-02 ワミレスコスメティックス株式会社 カチオン化ベシクル及びその組成物
KR20200098560A (ko) * 2017-12-08 2020-08-20 워밀레스 코스메틱스 가부시키가이샤 카티온화 베시클 및 그 조성물
CN111683650A (zh) * 2017-12-08 2020-09-18 和美令须化妆品株式会社 阳离子化囊泡及其组合物
KR102281703B1 (ko) 2017-12-08 2021-07-23 워밀레스 코스메틱스 가부시키가이샤 카티온화 베시클 및 그 조성물
CN111683650B (zh) * 2017-12-08 2021-11-05 和美令须化妆品株式会社 阳离子化囊泡及其组合物

Similar Documents

Publication Publication Date Title
Scheideler et al. Lipid nanocarriers for microRNA delivery
JP5674831B2 (ja) 薬物送達制御用経肺投与リポソーム
Ko et al. Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting
WO2023133946A1 (fr) Composé lipidique cationique, composition le contenant et son utilisation
US20200345641A1 (en) Lipid nanoparticles
US20110117026A1 (en) Methods and compositions for the delivery of bioactive compounds
JP2000516630A (ja) 全身への送達を増加させる新規のリポソーム複合体
Zhang et al. Lipid carriers for mRNA delivery
JP6570188B2 (ja) ｓｉＲＮＡ細胞内送達のための脂質膜構造体
WO2010110471A1 (fr) Structure membranaire lipidique
JP5787323B2 (ja) 脂質膜構造体
WO2010067617A1 (fr) Structure de membrane lipidique
AU2008295666B2 (en) Improved liposomes and uses thereof
Hu et al. Liposomes in drug delivery: Status and advances
WO2020262150A1 (fr) Nanoparticule lipidique
KR102537540B1 (ko) 만노스를 포함하는 지질 나노입자 또는 이의 용도
JP6384863B2 (ja) 脂質膜構造体
KR101916941B1 (ko) 플라스미드 디엔에이 전달용 고분자 나노입자 조성물 및 그의 제조방법
JP2006238839A (ja) 核酸の細胞内送達効率又は細胞内発現効率を向上させた組成物
Riccardi et al. Liposomes, transfersomes and niosomes: production methods and their applications in the vaccinal field
WO2015098907A1 (fr) Structure membranaire lipidique possédant une propriété de localisation intranucléaire
US20230190653A1 (en) Method for reducing off-target uptake or accumulation of agents
JP4904573B2 (ja) 目的物質の脳毛細血管内皮細胞への取り込みを亢進させるための組成物
WO2023246218A1 (fr) Lipide ionisable pour l'administration d'acides nucléiques et composition associée
WO2022176953A1 (fr) Nanoparticule lipidique

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09831723

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09831723

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP